MiR-210-3p Inhibits Proliferation and Migration of C6 Cells by Targeting Iscu

Hui He1, Juan Liu1, Wen Li1

  • 1Department of Human Anatomy, Medical School, Nantong University, Nantong, Jiangsu, People's Republic of China.

Insights

MicroRNA-210-3p inhibits glioma growth by targeting the Iscu gene. This microRNA and its target gene axis represent a promising therapeutic strategy for brain tumors.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Glioma, particularly glioblastoma, is a common and aggressive primary brain tumor with poor prognosis.
  • MicroRNAs are implicated in glioma development and present potential therapeutic targets.
  • The specific role and mechanism of miR-210-3p in glioma progression remain unclear.

Purpose of the Study:

  • To investigate the inhibitory effects of miR-210-3p on glioma cell proliferation and migration.
  • To elucidate the underlying mechanism involving the target gene Iscu.
  • To evaluate the in vivo impact of miR-210-3p on glioma growth.

Main Methods:

  • In vitro studies using C6 glioma cells to assess proliferation and migration.
  • In vivo experiments in immunodeficient mice implanted with C6 cells overexpressing miR-210-3p.
  • Analysis of miR-210-3p and Iscu gene expression.

Main Results:

  • miR-210-3p significantly inhibited proliferation and migration of C6 glioma cells in vitro.
  • Overexpression of miR-210-3p suppressed glioma tumor growth in vivo.
  • These effects were mediated by the regulation of the target gene Iscu.

Conclusions:

  • miR-210-3p plays a crucial role in preventing glioma growth.
  • The miR-210-3p/Iscu axis is a potential therapeutic target for glioma treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K